Merck's GARDASIL® Receives Expanded Approval for Males in China
GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males Merck (NYSE: MRK), known as MSD outside of the United States and Canada, ...